Concurrent Investment Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
6,460
-71
-1% -$13.1K 0.01% 924
2026
Q1
$1.23M Sell
6,531
-1,189
-15% -$251K 0.01% 801
2025
Q4
$1.53M Buy
7,720
+2,438
+46% +$493K 0.02% 661
2025
Q3
$1.07M Buy
5,282
+234
+5% +$41.5K 0.02% 635
2025
Q2
$888K Buy
5,048
+224
+5% +$33.7K 0.02% 635
2025
Q1
$649K Buy
4,824
+1,317
+38% +$173K 0.02% 668
2024
Q4
$443K Buy
3,507
+574
+20% +$85.3K 0.01% 706
2024
Q3
$487K Buy
2,933
+213
+8% +$32.2K 0.01% 627
2024
Q2
$362K Buy
2,720
+15
+0.6% +$1.81K 0.01% 679
2024
Q1
$284K Sell
2,705
-12
-0.4% -$1.08K 0.01% 690
2023
Q4
$205K Buy
+2,717
New +$172K 0.01% 764

Other funds holding THC

Concurrent Investment Advisors's THC Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its Tenet Healthcare (THC) stake by 1.1% in Q2 2026, selling an estimated $13.1K and leaving 6,460 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #924.

Concurrent Investment Advisors first reported a position in THC in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.53M in Q4 2025. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Concurrent Investment Advisors held 6,460 shares of Tenet Healthcare worth $1.21M as of Q2 2026.
  • Concurrent Investment Advisors sold 71 Tenet Healthcare shares in Q2 2026, an estimated $13.1K.
  • Tenet Healthcare made up 0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #924 holding.
  • Concurrent Investment Advisors first reported a position in Tenet Healthcare in Q4 2023 and has held it in 11 quarters since.
  • Concurrent Investment Advisors's Tenet Healthcare position peaked at $1.53M in Q4 2025.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.